Answers are grounded in this paper and cite their sources.
Evidence of a possible small benefit from PSA screening supports a grade C recommendation — not the U.S. Preventive Services Task Force's proposed grade D — for men 55 to 69 years of age, who should participate in screening decisions after discussion with a primary care provider.
No takes yet. Share an insight, caveat, or question.
McNaughton‐Collins et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: